164 related articles for article (PubMed ID: 29269125)
1. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
[TBL] [Abstract][Full Text] [Related]
2. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
Harms PW; Hovelson DH; Cani AK; Omata K; Haller MJ; Wang ML; Arps D; Patel RM; Fullen DR; Wang M; Siddiqui J; Andea A; Tomlins SA
Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
[TBL] [Abstract][Full Text] [Related]
3. Concomitant poroma and porocarcinoma.
Abarzúa Á; Álvarez-Véliz S; Moll-Manzur C
An Bras Dermatol; 2017; 92(4):550-552. PubMed ID: 28954110
[TBL] [Abstract][Full Text] [Related]
4. Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma.
Zahn J; Chan MP; Wang G; Patel RM; Andea AA; Bresler SC; Harms PW
J Cutan Pathol; 2019 Sep; 46(9):659-664. PubMed ID: 31012122
[TBL] [Abstract][Full Text] [Related]
5. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
Li P; Busam KJ
J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
[TBL] [Abstract][Full Text] [Related]
6. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
[TBL] [Abstract][Full Text] [Related]
7. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
[TBL] [Abstract][Full Text] [Related]
8. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
9. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
11. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
12. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
Tateyama H; Eimoto T; Tada T; Inagaki H; Nakamura T; Yamauchi R
Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
[TBL] [Abstract][Full Text] [Related]
13. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Characteristics of Poroma and Porocarcinoma.
Kawaguchi M; Kato H; Imada H; Miyazaki T; Matsuyama K; Seishima M; Matsuo M
J Comput Assist Tomogr; 2021 May-Jun 01; 45(3):447-451. PubMed ID: 33797441
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
Wollina U; Castelli E; Rülke D
Recent Results Cancer Res; 1995; 139():303-16. PubMed ID: 7541147
[TBL] [Abstract][Full Text] [Related]
16. P53 protein expression in eccrine poroma and porocarcinoma.
Akalin T; Sen S; Yücetürk A; Kandiloğlu G
Am J Dermatopathol; 2001 Oct; 23(5):402-6. PubMed ID: 11801771
[TBL] [Abstract][Full Text] [Related]
17. Apocrine poroma of the breast.
Azma A; Tawfik O; Casparian JM
Breast J; 2001; 7(3):195-8. PubMed ID: 11469936
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
Gu LH; Ichiki Y; Kitajima Y
J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
[TBL] [Abstract][Full Text] [Related]
19. Eccrine poroma and porocarcinoma on the same unusual location: report on two cases.
Ma H; Liao M; Qiu S; Lu R; Lu C
An Bras Dermatol; 2015; 90(3 Suppl 1):69-72. PubMed ID: 26312678
[TBL] [Abstract][Full Text] [Related]
20. Cuticular Poroma: A Rare Poroma Variant Simulating a Malignant Neoplasm That Often Harbors YAP1::NUTM1 Fusions Similar to Their Conventional Counterparts.
Kolm I; Konstantinova AM; Kutzner H; Barghorn A; Vanecek T; Mangana J; Kazakov DV
Am J Dermatopathol; 2023 Aug; 45(8):544-548. PubMed ID: 37335840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]